These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21559455)

  • 1. Antibody response to Shiga toxins in Argentinean children with enteropathic hemolytic uremic syndrome at acute and long-term follow-up periods.
    Fernández-Brando RJ; Bentancor LV; Mejías MP; Ramos MV; Exeni A; Exeni C; Laso Mdel C; Exeni R; Isturiz MA; Palermo MS
    PLoS One; 2011 Apr; 6(4):e19136. PubMed ID: 21559455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls.
    Guirro M; Piazza RM; de Souza RL; Guth BE
    BMC Infect Dis; 2014 Jun; 14():320. PubMed ID: 24919599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.
    Ludwig K; Sarkim V; Bitzan M; Karmali MA; Bobrowski C; Ruder H; Laufs R; Sobottka I; Petric M; Karch H; Müller-Wiefel DE
    J Clin Microbiol; 2002 May; 40(5):1773-82. PubMed ID: 11980959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.
    Melli LJ; Zylberman V; Hiriart Y; Lauche CE; Baschkier A; Pardo R; Miliwebsky E; Chinen I; Rivas M; Goldbaum FA; Ugalde JE; Comerci DJ; Ciocchini AE
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31826960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
    Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G
    Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome.
    Ludwig K; Karmali MA; Sarkim V; Bobrowski C; Petric M; Karch H; Müller-Wiefel DE;
    J Clin Microbiol; 2001 Jun; 39(6):2272-9. PubMed ID: 11376069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemolytic uremic syndrome in children of Mendoza, Argentina: association with Shiga toxin-producing Escherichia coli infection].
    Rivas M; Balbi L; Miliwebsky ES; García B; Tous MI; Leardini NA; Prieto MA; Chillemi GM; de Principi ME
    Medicina (B Aires); 1998; 58(1):1-7. PubMed ID: 9674201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.
    Rivas M; Miliwebsky E; Chinen I; Roldán CD; Balbi L; García B; Fiorilli G; Sosa-Estani S; Kincaid J; Rangel J; Griffin PM;
    Foodborne Pathog Dis; 2006; 3(1):88-96. PubMed ID: 16602984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
    Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
    Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission].
    Rivas M; Miliwebsky E; Chinen I; Deza N; Leotta GA
    Medicina (B Aires); 2006; 66 Suppl 3():27-32. PubMed ID: 17354474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E; Salmenlinna S; Halkilahti J; Jahnukainen T; Korhonen L; Virkkala T; Rimhanen-Finne R; Nuutinen M; Kataja J; Arikoski P; Linkosalo L; Bai X; Matussek A; Jalanko H; Saxén H
    Pediatr Nephrol; 2020 Sep; 35(9):1749-1759. PubMed ID: 32323005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of a product anti-Shiga toxin for prevention of the hemolytic uremic syndrome].
    Hiriart Y; Pardo R; Bukata L; Lauché C; Muñoz L; Colonna M; Goldbaum F; Sanguineti S; Zylberman V
    Medicina (B Aires); 2018; 78(2):107-112. PubMed ID: 29659360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
    Sheoran AS; Dmitriev IP; Kashentseva EA; Cohen O; Mukherjee J; Debatis M; Shearer J; Tremblay JM; Beamer G; Curiel DT; Shoemaker CB; Tzipori S
    Infect Immun; 2015 Jan; 83(1):286-91. PubMed ID: 25368111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
    J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Shiga toxin-producing Escherichia coli by sandwich enzyme-linked immunosorbent assay using chicken egg yolk IgY antibodies.
    Parma YR; Chacana PA; Lucchesi PM; Rogé A; Granobles Velandia CV; Krüger A; Parma AE; Fernández-Miyakawa ME
    Front Cell Infect Microbiol; 2012; 2():84. PubMed ID: 22919675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga Toxin-Producing
    Bai X; Mernelius S; Jernberg C; Einemo IM; Monecke S; Ehricht R; Löfgren S; Matussek A
    Front Cell Infect Microbiol; 2018; 8():125. PubMed ID: 29765909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
    Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G
    Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand.
    Leotta GA; Miliwebsky ES; Chinen I; Espinosa EM; Azzopardi K; Tennant SM; Robins-Browne RM; Rivas M
    BMC Microbiol; 2008 Mar; 8():46. PubMed ID: 18366637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157.
    Kawano K; Okada M; Haga T; Maeda K; Goto Y
    Eur J Clin Microbiol Infect Dis; 2008 Mar; 27(3):227-32. PubMed ID: 18071766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.